Abnormal Fhit expression in malignant and premalignant lesions of the cervix

被引:0
|
作者
Birrer, MJ [1 ]
Hendricks, D [1 ]
Farley, J [1 ]
Sundborg, MJ [1 ]
Bonome, T [1 ]
Walts, MJ [1 ]
Geradts, J [1 ]
机构
[1] NCI, Med Branch, Div Clin Sci, NIH, Rockville, MD 20850 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Genetic analysis of cervical cancer has demonstrated frequent allelic loss in the 3p chromosomal region. The newly described gene FHIT is located at chromosome region 3p14.2, and its expression has been demonstrated previously by reverse transcription-PCR to be abnormal in a majority of cervical cancer cell lines, In this study, 98 different lesions of the cervix were examined for Fhit expression by immunohistochemical staining Whereas normal cervical epithelium demonstrated diffuse, moderate to intense cytoplasmic staining, many pathological lesions of the cervix displayed reduced or absent Fhit expression. Sixty-one percent of squamous carcinomas and 40% of adenocarcinomas of the cervix had abnormal Fhit expression, Sixty-five preneoplastic lesions of the cervix were examined, Eleven of 33 high-grade squamous intraepithelial lesions and 1 of 12 low-grade squamous intraepithelial lesions had abnormal Fhit expression, In summary, Fhit expression is frequently abnormal in both glandular and squamous cervical cancers, with a higher frequency of Fhit alterations observed in squamous lesions, In addition, abnormal Fhit expression can he detected in some preneoplastic lesions of the ectocervix, Alterations in Fhit expression may be an important marker of early progression in the development of cancers of the cervix.
引用
收藏
页码:5270 / 5274
页数:5
相关论文
共 50 条
  • [1] PREMALIGNANT AND MALIGNANT LESIONS OF CERVIX
    BHASKARAN, CS
    BHAGYALAKSHMI, M
    RANI, LU
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 1978, 67 (JAN) : 97 - 105
  • [2] Laminin receptor 1 expression in premalignant and malignant squamous lesions of the cervix
    Kurdoglu, Mertihan
    Kurdoglu, Zehra
    Kucukaydin, Zehra
    Erten, Remzi
    Bulut, Guelay
    Ozen, Suleyman
    [J]. BIOTECHNIC & HISTOCHEMISTRY, 2024, 99 (03) : 174 - 181
  • [3] DEFINITIVE DIAGNOSIS OF PREMALIGNANT AND EARLY MALIGNANT LESIONS OF CERVIX
    EMIG, OR
    HUNTER, WC
    [J]. WESTERN JOURNAL OF SURGERY OBSTETRICS AND GYNECOLOGY, 1961, 69 (05): : 280 - &
  • [5] lntegrin alpha(v) beta(3) expression in premalignant and malignant lesions of the uterine cervix
    Guerra, L. A.
    Edelweiss, M. I.
    Rosa, D. D.
    Silveira, D. A.
    Marcolan, A. M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S735 - S735
  • [6] Validation of ProEx C as a biomarker for premalignant and malignant lesions of the cervix
    Wang, H.
    Terinate, P.
    Gao, Y.
    Wei, M.
    Poognothai, A. R.
    Kalra, K. L.
    [J]. VIRCHOWS ARCHIV, 2011, 459 : S252 - S252
  • [7] CYTOLOGICAL AND COLPOSCOPIC EVALUATION IN PREMALIGNANT AND EARLY MALIGNANT LESIONS OF THE CERVIX
    SINGH, V
    VERMA, K
    BHARGAVA, VL
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 1983, 78 : 54 - 59
  • [8] Loss of FHIT expression in squamous cell carcinoma and premalignant lesions of the larynx
    Yuge, T
    Nibu, K
    Kondo, K
    Shibahara, J
    Tayama, N
    Sugasawa, M
    [J]. ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2005, 114 (02): : 127 - 131
  • [9] LIGHT MICROSCOPIC EVALUATION OF APOPTOSIS IN PREMALIGNANT AND MALIGNANT LESIONS OF THE UTERINE CERVIX
    Bhardwaj, Subhash
    Sarngal, Shiffali
    Choudhary, Mehnaz
    [J]. JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2016, 5 (16): : 774 - 777
  • [10] INFLUENCE OF ORAL-CONTRACEPTIVES ON THE INCIDENCE OF PREMALIGNANT AND MALIGNANT LESIONS OF THE CERVIX
    ANDOLSEK, L
    KOVACIC, J
    KOZUH, M
    LITT, B
    [J]. CONTRACEPTION, 1983, 28 (06) : 505 - 519